Xarelto Lawsuits Claim Blood Thinner Is Linked to Fatal Bleeding

July 24, 2014 Last Updated on April 4, 2019

Important Information

Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.

Comments |

Case Update

Settlement Reached - April 4, 2019

Bayer AG and Johnson & Johnson have agreed to pay $775 million to settle more than 25,000 Xarelto lawsuits. 

Note that this settlement applies only to the individual cases filed by patients and/or their loved ones; this settlement is not the result of any class action lawsuit. To be eligible for the settlement, people needed to have had their cases on file by April 4th, 2019, according to the attorneys we work with. If you have not filed a suit and believe you were harmed by Xarelto, contact an attorney in your area for more information.

At A Glance

This Alert Affects:
Patients who suffered serious bleeding events after taking Xarelto.
What Is Xarelto?
Xarelto (rivaroxaban) is a blood thinner (anticoagulant) that is prescribed following knee and hip replacement surgeries to prevent the risk of blood clots. Xarelto has also been approved for use in patients with non-valvular atrial fibrillation (irregular heartbeats) to prevent the risk of strokes and systemic embolisms (severe blood clots).
What Injuries Have Been Linked to Xarelto?
Gastrointestinal bleeding, cerebral hemorrhaging and other types of internal bleeding.
Who's Getting Sued?
Bayer, Johnson & Johnson, and Johnson & Johnson's Janssen unit.
Why?
The lawsuits claim the drug is defective and unreasonably dangerous and that doctors and patients were not properly warned about the drug's risk of irreversible bleeding.
What Could I Get from a Lawsuit?
Compensation for medical bills, lost wages, pain and suffering, and in cases of death, funeral expenses and loss of projected earnings.
Type of Lawsuit
Mass Tort